Net Cash Provided by (Used in) Operating Activities in USD of BIO-TECHNE Corp from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
BIO-TECHNE Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to Q3 2025.
  • BIO-TECHNE Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2025 was $27.6M, a 56.8% decline year-over-year.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Operating Activities for 2025 was $288M, a 3.82% decline from 2024.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Operating Activities for 2024 was $299M, a 17.5% increase from 2023.
  • BIO-TECHNE Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was $254M, a 21.8% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)

BIO-TECHNE Corp Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $27.6M -$36.3M -56.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q3 2024 $63.9M +$4.51M +7.59% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q3 2023 $59.4M +$3.3M +5.89% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q3 2022 $56.1M +$7.65M +15.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q3 2021 $48.4M -$17.6M -26.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q3 2020 $66M +$25.5M +62.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q3 2019 $40.5M +$1.09M +2.77% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q3 2018 $39.4M -$5.25M -11.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q3 2017 $44.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q3 2013 $32.6M +$3.32M +11.4% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q3 2012 $29.3M -$5.17M -15% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q3 2011 $34.4M +$3.73M +12.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 $30.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09

BIO-TECHNE Corp Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $288M -$11.4M -3.82% Jul 1, 2024 Jun 30, 2025 10-K 2025-08-22
2024 $299M +$44.6M +17.5% Jul 1, 2023 Jun 30, 2024 10-K 2025-08-22
2023 $254M -$70.9M -21.8% Jul 1, 2022 Jun 30, 2023 10-K 2025-08-22
2022 $325M -$26.9M -7.64% Jul 1, 2021 Jun 30, 2022 10-K 2024-08-22
2021 $352M +$147M +71.6% Jul 1, 2020 Jun 30, 2021 10-K 2023-08-23
2020 $205M +$23.6M +13% Jul 1, 2019 Jun 30, 2020 10-K 2022-08-24
2019 $182M +$11.3M +6.61% Jul 1, 2018 Jun 30, 2019 10-K 2021-08-25
2018 $170M +$26.6M +18.5% Jul 1, 2017 Jun 30, 2018 10-K 2020-08-26
2017 $144M -$436K -0.3% Jul 1, 2016 Jun 30, 2017 10-K/A 2019-11-06
2016 $144M Jul 1, 2015 Jun 30, 2016 10-K 2018-08-27
2013 $124M -$3.18M -2.51% Jul 1, 2012 Jun 30, 2013 10-K 2013-08-29
2012 $127M -$448K -0.35% Jul 1, 2011 Jun 30, 2012 10-K 2013-08-29
2011 $127M +$15.9M +14.3% Jul 1, 2010 Jun 30, 2011 10-K 2013-08-29
2010 $111M Jul 1, 2009 Jun 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.